• SENSEX 79,454.47
    -880.34 (--1.10%)
  • BANKNIFTY 53,595.25
    -770.40 (--1.42%)
  • TVS Holdings
    8,818.25 7,755.00(%)
  • Angel One
    2,253.00 1,942.00(%)
  • Mazagon Dock
    2,962.90 3,170.00(%)
  • Tata Motors
    710.85 1,179.05(%)
  • Nuvama Wealth
    6,031.50 7,647.95(%)
  • Bharat Dynamics
    1,595.00 1,794.70(%)
  • Yes Bank
    20.36 27.41(%)
  • Bharat Electron
    321.80 340.35(%)
  • Paras Defence
    1,476.00 1,592.75(%)
  • Larsen & Toubro
    3,477.55 3,963.00(%)
  • Cochin Shipyard
    1,491.70 2,977.10(%)
  • Suzlon Energy
    50.96 37.95(%)
  • Jio Financial
    242.15 198.60(%)
  • Apollo Micro Sys
    137.00 157.00(%)
  • Titan Company
    3,530.00 3,866.15(%)
  • Hind.Aeronautics
    4,578.95 5,675.00(%)
  • Reliance Industr
    1,372.05 1,115.55(%)
  • Adani Green
    854.50 758.00(%)
  • Canara Bank
    98.40 129.35(%)
  • Dixon Technolog.
    15,063.05 7,935.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

J B Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 303.0
  • ISIN : INE572A01036
1,524.60 -19 (-1.26%)
  • As on 09 May 2025 (EOD)

  • Today’s Low

    1,510.10

  • Today’s High

    1,553.00

  • Open

    1,543.90

  • Perv Close

    1,544.00

  • 52W Low

    1,385.75

  • 52W High

    2,030.00

Key Indicators

  • P/E(TTM)

    37.82

  • Mar.Cap (₹Cr.)

    23,734.55

  • Div & Yield %

    0.80

  • Book Value(₹)

    202.81

  • Debt-Equity Ratio

    -1.26

  • AGM Date

    09-May-2025

  • EPS

    40.38

  • P/E Ratio

    37.82

Financials Ratios

  • Debt-Equity Ratio

    0.18

  • Mar.Cap (₹Cr.)

    23,734.55

  • RONW (%)

    20.45

  • ROCE (%)

    24.90

Score Board

  • Equity (₹ in Cr.)

    15.57

  • BV (₹)

    202.80

  • Sales( ₹ in Cr.)

    3,298.64

  • NP (in Cr.)

    531.66

  • NP Var(%)

    38.0

  • Div%

    1225.0

  • CPS (₹)

    42.80

  • EPS (₹)

    34.20

  • Traded Value (₹ in Lakhs)

    23,776.58

  • 52 Week High

    2,030.00

  • 52 Week Low

    1,385.75

  • Price BSE

    1527.0

  • Price NSE

    1,525.00

  • Market Capital( in Cr.)

    23,776.58

  • P/C Ratio

    35.60

  • P/E Ratio

    44.70

  • Price Vs.BV

    34.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19
Other Income 34.67 8.65 38.61 115.92 47.13 36.53
Stock Adjustments 49.22 27.48 25.57 15.70 -2.53 21.66
Total Income 3,382.53 2,920.29 2,254.06 2,023.62 1,685.34 1,559.38
EXPENDITURE :            
Raw Materials 1,158.29 1,064.21 769.27 641.46 566.61 558.02
Power and Fuel Cost 87.95 91.44 71.37 62.60 61.54 63.29
Employee Cost 565.38 499.95 399.06 305.98 293.78 257.98
Other Manufacturing Expenses 120.93 106.13 97.36 84.69 77.06 82.52
Selling and Administration Expenses 446.93 394.90 305.91 204.68 205.02 212.12
Miscellaneous Expenses 88.96 90.33 63.58 55.96 73.75 56.79
Employee Benefit Expenses 565.38 499.95 399.06 305.98 293.78 257.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,468.44 2,246.95 1,706.54 1,355.37 1,277.77 1,230.71
Operating Profit 914.09 673.34 547.52 668.25 407.59 328.67
Interest 40.52 34.31 4.95 7.19 2.94 4.57
Gross Profit 873.57 639.03 542.57 661.06 404.65 324.10
Depreciation 135.24 111.99 71.28 67.36 65.09 54.82
Profit Before Tax 738.33 527.04 471.29 593.70 339.56 269.28
Current Tax 145.49 83.35 122.50 137.50 82.02 75.92
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 49.49 54.80 -12.21 9.12 -10.60 11.30
Reported Net Profit 543.36 388.89 361.00 447.08 268.14 182.06
Extraordinary Items 11.70 2.92 27.75 46.97 12.62 12.09
Adjusted Net Profit 531.66 385.97 333.25 400.11 255.52 169.97
Adjustment below Net Profit -3.71 0.13 0.07 -12.50 -5.06 0.00
P & L Balance brought forward 2,070.16 1,808.73 1,575.18 1,214.01 1,092.46 935.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 156.99 127.59 127.52 73.42 141.53 20.15
P & L Balance carried down 2,452.82 2,070.16 1,808.73 1,575.18 1,214.01 1,097.60
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,225.00 887.50 825.00 825.00 550.00 250.00
Dividend Per Share(Rs) 12.25 17.75 16.50 16.50 11.00 5.00
Earnings Per Share-Unit Curr 35.01 50.26 46.71 57.85 34.70 22.69
Earnings Per Share(Adj)-Unit Curr 35.01 25.13 23.36 28.93 17.35 11.35
Book Value 185.98 315.65 272.21 233.75 187.02 185.02
Book Value(Adj)-Unit Curr 185.98 157.83 136.11 116.88 93.51 92.51

Shareholding Pattern

  • Promoter Group

    47.84%

  • Public Share Holding

    52.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 74,481,519 47.84 74,481,519 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 74,481,519 47.84 74,481,519 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,000 0.00 3,000 3
Foreign Bank 1,000 0.00 1,000 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 28,484,742 18.30 28,484,742 256
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,749,538 1.77 2,746,538 13
Mutual Funds / UTI 25,320,571 16.26 25,318,571 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,063,845 0.68 1,063,845 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 57,625,696 37.02 57,617,696 319
2] Non Institution
Bodies Corporate 772,298 0.50 767,298 389
Clearing Members 4 0.00 4 1
Directors of their Relatives 50 0.00 50 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,009,839 0.65 1,009,839 1,742
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 534,978 0.34 534,978 1,025
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,686,716 1.08 1,686,716 3
Individuals holding nominal share capital up to Rs. 1 lakh 18,984,898 12.20 18,491,328 60,461
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,097 0.00 2,097 4
Others 579,113 0.37 579,113 2
Sub Total 23,569,993 15.14 23,071,423 63,628
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 155,677,208 100.00 155,170,638 63,948

Company Background

J B Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • J B Chemicals & Pharmaceuticals Ltd
  • BSE Code : 303.0
  • ISIN : INE572A01036

  • Incorporation Year

    1976

  • Registered Office

    Neelam Centre 4th Floor
    B-Wing Hind Cycle Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-2482 2222/2493 0918

  • FAX

    91-022-24930534

  • Chairman

    Arun Duggal

  • Managing Director

  • Company Secretary

    SANDEEP PHADNIS

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Datamatics Financial Services
    Plot No B-5 MIDC ,
    Part B Cross Lane ,Marol Andheri(E)
    Mumbai - Mumbai-400093

J B Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
J B Chemicals & 1,527.30 3,333.32 3,298.64 37.82 24.83
Abbott India 30,147.65 6,097.18 5,848.91 48.01 44.71
Astrazeneca Phar 7,992.35 1,330.33 1,295.53 206.04 33.26
P & G Health Ltd 5,030.35 1,166.89 1,151.26 35.30 39.76
Glaxosmi. Pharma 2,758.30 3,530.73 3,407.25 54.85 44.44
Cipla 1,478.50 17,645.00 16,574.34 25.35 20.10
Amrutanjan Healt 692.60 437.58 421.23 40.60 20.84
Guj. Themis Bio. 269.15 174.19 169.82 55.72 44.82
Fermenta Biotec. 258.90 315.24 307.09 24.54 4.10
Bliss GVS Pharma 112.05 638.96 605.46 25.64 11.19
Ambalal Sarabhai 35.20 11.70 3.81 15.04 1.92